TFG Asset Management’s Soleno Therapeutics SLNO Stock Holding History

TFG Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-102,125	Closed	-$3.42M	–	44
2026 Q1	$3.42M	Buy	+102,125	New	+$4M	0.66%	23

TFG Asset Management's SLNO Position: Q2 2026 in Review

TFG Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 102,125 shares — an estimated $3.42M sold.

TFG Asset Management first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $3.42M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

TFG Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
TFG Asset Management sold 102,125 Soleno Therapeutics shares in Q2 2026, an estimated $3.42M.
TFG Asset Management first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
TFG Asset Management's Soleno Therapeutics position peaked at $3.42M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.